Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

[Pharmacokinetic evaluation of afobazole pharmaceutical composition with modified release].

Bochkov PO, Litvin AA, Kolyvanov GB, Viglinskaya AO, Zherdev VP, Blynskaya EV, Alekseev KV.

Eksp Klin Farmakol. 2015;78(3):27-9. Russian.

PMID:
26036008
2.

[EVALUATION OF THE PHARMACOKINETIC INTERACTION OF AFOBAZOLE WITH CYP2C9 ENZYME DRUG SUBSTRATE OF CYTOCHROME P450].

Gribakina OG, Kolyvanov GB, Litvin AA, Smirnov VV, Shevchenko RV, Zherdev VP.

Eksp Klin Farmakol. 2015;78(12):18-22. Russian.

PMID:
27051923
3.

Comparison of pharmacokinetics and relative bioavailability of tablets and substance of new dipeptide neuroleptic dilept.

Shevchenko RV, Litvin AA, Kolyvanov GB, Zherdev VP, Smirnov VV.

Bull Exp Biol Med. 2014 Oct;157(6):735-7. doi: 10.1007/s10517-014-2655-1. Epub 2014 Oct 29.

PMID:
25348562
4.

[Specific features in pharmacokinetics of the original neuroleptic dilept in animals and humans].

Shevchenko RV, Litvin AA, Kolyvanov GB, Boĭko SS, Zherdev VP.

Eksp Klin Farmakol. 2014;77(7):23-6. Russian.

PMID:
25322650
5.

[Pharmacokinetic evaluation of a new prolonged dosage form of afobazole in comparison to commercially available tablets].

Bochkov PO, Litvin AA, Kolyvanov GB, Zherdev VP, Blynskaia EV, Grushevskaia LN, Illarionov AA.

Eksp Klin Farmakol. 2013;76(11):33-5. Russian.

PMID:
24555231
6.

[Clinic pharmacokinetics of a new original antipsychotic drug Dilept].

Shevchenko RV, Litvin AA, Kolyvanov GB, Boĭko SS, Zherdev VP, Serebrova SIu, Ivashkina NIu, Neznamov GG, Siuniakov SA.

Eksp Klin Farmakol. 2013;76(6):34-7. Russian.

PMID:
24003489
7.

[Evaluation of pharmacokinetic interaction of aphobazole with CYP1A2 drug-substrate in experiments].

Novitskaia IaG, Litvin AA, Viglinskaia AO, Zherdev VP.

Eksp Klin Farmakol. 2013;76(6):30-3. Russian.

PMID:
24003488
8.

[In vivo study of the pharmacokinetic interaction of afobazole and losartan (cytochrome CYP2C9 substrate)].

Gribakina OG, Kolyvanov GB, Litvin AA, Zherdev VP, Seredin SB.

Eksp Klin Farmakol. 2013;76(3):35-7. Russian.

PMID:
23767102
9.

Excretion of compound M-11 and its metabolites with urine and feces in rats.

Bastrygin DV, Viglinskaya AO, Kolyvanov GB, Litvin AA, Bochkov PO, Mozhaeva TY, Zherdev VP.

Bull Exp Biol Med. 2012 Sep;153(5):707-9.

PMID:
23113264
10.

[Panavir in combined treatment of chronic cystitis with hyperplastic changes in urinary bladder mucosa].

Aboian IA, Aboian VÉ, Zin'kovskaia OV, Sknar VA, Kucherov VA, Stovbun SV, Safronov DIu, Litvin AA.

Urologiia. 2011 Nov-Dec;(6):25-6, 28-9. Russian.

PMID:
22448476
11.

[Pharmacokinetics of afobazole metabolite (M-11) in rats].

Bastrygin DV, Viglinskaia AO, Kolyvanov GB, Litvin AA, Bochkov PO, Mozhaeva TIa, Zherdev VP.

Eksp Klin Farmakol. 2011;74(7):22-6. Russian.

PMID:
21894764
12.

Does femoral venous pressure measurement correlate well with intrabladder pressure measurement? A multicenter observational trial.

De Keulenaer BL, Regli A, Dabrowski W, Kaloiani V, Bodnar Z, Cea JI, Litvin AA, Davis WA, Palermo AM, De Waele JJ, Malbrain ML.

Intensive Care Med. 2011 Oct;37(10):1620-7. doi: 10.1007/s00134-011-2298-x. Epub 2011 Jul 8.

PMID:
21739341
13.

[Comparative pharmacokinetics and relative bioavailability of magnesium-containing drugs].

Zherdev VP, Kolyvanov GB, Litvin AA, Solodakhin AV, Burmistrov VA.

Eksp Klin Farmakol. 2010 Dec;73(12):28-30. Russian.

PMID:
21395014
14.

Comparative analysis of tissue availability for afobazole and compound M-11.

Viglinskaya AO, Bastrygin DV, Kolyvanov GB, Litvin AA, Zherdev VP, Mozhaeva TY.

Bull Exp Biol Med. 2010 Sep;149(3):318-9.

PMID:
21246091
15.

[Model study of afobazole distribution in pregnant and lactating female rats and infant rat pups].

Shreder OV, Kolyvanov GB, Litvin AA, Bastrygin DV, Shreder ED, Solomina AS, Viglinskaia AO, Zabrodina VV, Zherdev VP, Durnev AD, Seredenin SB.

Eksp Klin Farmakol. 2010 Aug;73(8):17-20. Russian.

PMID:
20919552
16.

[Comparative pharmacokinetics of dihydroquercetin in rats upon peroral administration of a parent compound and liposomal flamen D].

Zherdev VP, Kolyvanov GB, Litvin AA, Sariev AK, Viglinskaia AO, Gekkiev BI, Grigor'ev AM, Gorlov VV.

Eksp Klin Farmakol. 2010 Jan;73(1):23-5. Russian.

PMID:
20184284
17.

[Protective activity of panavir in experimental rabies infection].

Gribencha SV, Litvin AA, Kokhnovich MA, Sergienko VI, Stovbun SV, Iakimuk PV, Bezmen VG.

Antibiot Khimioter. 2009;54(5-6):31-6. Russian.

PMID:
20052915
18.

[Effect of Panavir on Herpes simplex virus types 1 and 2 proteins synthesis in cell culture].

Klimova RR, Kushch AA, Fedorova NE, Litvin AA.

Antibiot Khimioter. 2009;54(3-4):18-20. Russian.

PMID:
19711844
19.

[Preclinical and clinical studies of the efficacy of Panavir in therapy for tick-borne encephalitis].

Litvin AA, Ratnikova LI, Deriabin PG.

Vopr Virusol. 2009 May-Jun;54(3):26-32. Russian.

PMID:
19537094
20.

[Antiviral activity of panavir in experimental Measles virus infection in cell cultures].

Markushin SG, Litvin AA.

Antibiot Khimioter. 2009;54(1-2):14-6. Russian.

PMID:
19499711

Supplemental Content

Loading ...
Support Center